A Review of Preventative Methods against Human Leishmaniasis Infection

PLoS Neglected Tropical Diseases

Volumn 7, Issue 6, 2013, Pages

  Stockdale, Lisa ^a,b   Newton, Robert ^b,c,d  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF YORK   (United Kingdom)

^c UGANDA VIRUS RESEARCH INSTITUTE   (Uganda)

^d INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LEISHMANIA VACCINE;

ANIMAL RESERVOIR CONTROL; BIBLIOGRAPHIC DATABASE; DISEASE CARRIER; DISEASE TRANSMISSION; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN RESERVOIR CONTROL; LABORATORY DIAGNOSIS; LEISHMANIASIS; LITERATURE; MORBIDITY; MORTALITY; NONHUMAN; OUTCOMES RESEARCH; PREVALENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK; VECTOR CONTROL; INFECTION CONTROL; PROCEDURES;

COMMUNICABLE DISEASE CONTROL; HUMANS; LEISHMANIASIS;

EID: 84879510999     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002278     Document Type: Review

References (69)

1. Quinnell RJ, Courtenay O, (2009) Transmission, reservoir hosts and control of zoonotic visceral leishmaniasis. Parasitology 136: 1915-1934 Available: http://www.ncbi.nlm.nih.gov/pubmed/19835643.
2. Desjeux P, (1996) Public Health Aspects and Control. Clinics in Dermatology 14: 417-423.
3. Markle W, Makhoul K, (2004) Cutaneous Leishmaniasis Recognition and Treatment. American Family Physician 69: 1455-1460 Available: http://www.aafp.org/afp/2004/0315/p1455.html.
4. Sharma U, Singh S, (2008) Insect vectors of Leishmania: distribution, physiology and their control. Journal of vector borne diseases 45: 255-272 Available: http://www.ncbi.nlm.nih.gov/pubmed/19248652.
5. Desjeux P, (2010) Prevention of Leishmania donovani infection: Vector control is the key to the success of the global elimation strategy. British Medical Journal 341: c6751 Available: http://www.bmj.com/cgi/doi/10.1136/bmj.c7090.
6. WHO (2010) Control of the leishmaniases. World Health Organization technical report series. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3307017&tool=pmcentrez&rendertype=abstract.
7. Alvar J, Vélez ID, Bern C, Herrero M, Desjeux P, et al. (2012) Leishmaniasis Worldwide and Global Estimates of Its Incidence. PLoS ONE 7: e35671 Available: http://dx.plos.org/10.1371/journal.pone.0035671.
8. Hotez PJ, Remme JHF, Buss P, Alleyne G, Morel C, et al. (2004) Combating tropical infectious diseases: report of the Disease Control Priorities in Developing Countries Project. Clinical infectious diseases 38: 871-878 Available: http://www.ncbi.nlm.nih.gov/pubmed/14999633.
9. WHO (2000) World Health Report 2000. Health Systems: Improving Performance. Geneva.
10. Desjeux P, (2001) The increase in risk factors for leishmaniasis worldwide. Transactions of the Royal Society of Tropical Medicine and Hygiene 95: 239-243 Available: http://www.ncbi.nlm.nih.gov/pubmed/11490989.
11. Gill G, Beeching N (2009) Visceral Leishmaniasis. Tropical Medicine, 6th Edition. pp. 74-79. Available: http://eu.wiley.com/WileyCDA/WileyTitle/productCd-140518048X,descCd-authorInfo.html.
12. Kassi M, Kassi M, Afghan AK, Rehman R, Kasi PM, (2008) Marring leishmaniasis: the stigmatization and the impact of cutaneous leishmaniasis in Pakistan and Afghanistan. PLoS neglected tropical diseases 2: e259 Available: http://dx.plos.org/10.1371/journal.pntd.0000259.
13. Hotez PJ, (2008) Stigma: the stealth weapon of the NTD. PLoS neglected tropical diseases 2: e230 Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2322832&tool=pmcentrez&rendertype=abstract.
14. Singh S, (2006) New developments in diagnosis of leishmaniasis. The Indian journal of medical research 123: 311-330 Available: http://www.ncbi.nlm.nih.gov/pubmed/22065060.
15. Chappuis F, Sundar S, Hailu A, Ghalib H, Rijal S, et al. (2007) Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nature reviews Microbiology 5: 873-882 Available: http://www.ncbi.nlm.nih.gov/pubmed/17938629.
16. Alemeida Silva L, Dardo Romero H, Nogueira Nascentes GA, Costa RT, Rodrigues V, et al. (2011) Antileishmania immunological tests for asymptomatic subjects living in a visceral leishmaniasis-endemic area in Brazil. The American journal of tropical medicine and hygiene 84: 261-266 Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3029179&tool=pmcentrez&rendertype=abstract.
17. Gidwani K, Rai M, Chakravarty J, Boelaert M, Sundar S, (2009) Evaluation of leishmanin skin test in Indian visceral leishmaniasis. The American journal of tropical medicine and hygiene 80: 566-567 Available: http://www.ncbi.nlm.nih.gov/pubmed/19346376.
18. Moher D, Liberati A, Tetzlaff J, Altman DG, (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS medicine 6: e1000097 Available: http://dx.plos.org/10.1371/journal.pmed.1000097.
19. Short H, (1927) The diagnosis of kala-azar. Trop Dis Bull 44: 145-150.
20. Palatnik-de-Sousa CB, Renata W, Santos DOS, Teodoro R, Costa DA, et al. (2001) Impact of canine control on the epidemiology of canine and human visceral leishmaniasis in Brazil. Am J Trop Med Hyg 65: 510-517.
21. Lysenko AJ, (1971) Distribution of leishmaniasis in the Old World. Bulletin of the World Health Organization 44: 515-520 Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2427824&tool=pmcentrez&rendertype=abstract.
22. Nicolle C, Comte C, (1908) Origine canine du Kala-azar. Bull Soc Pathol Exot 1: 299-301.
23. Travi BL, Ferro C, Cadena H, Montoya-Lerma J, Adler GH, (2002) Canine visceral leishmaniasis: dog infectivity to sand flies from non-endemic areas. Research in veterinary science 72: 83-86 Available: http://www.ncbi.nlm.nih.gov/pubmed/12002643.
24. Moreira ED, Mendes de Souza VM, Sreenivasan M, Nascimento EG, Pontes de Carvalho L, (2004) Assessment of an optimized dog-culling program in the dynamics of canine Leishmania transmission. Veterinary parasitology 122: 245-252 Available: http://www.ncbi.nlm.nih.gov/pubmed/15262002.
25. Palatnik-de-Sousa CB, Silva-Antunes I, Morgado ADA, Menz I, Palatnik M, et al. (2009) Decrease of the incidence of human and canine visceral leishmaniasis after dog vaccination with Leishmune in Brazilian endemic areas. Vaccine 27: 3505-3512 Available: http://www.ncbi.nlm.nih.gov/pubmed/19464528.
26. Akhavan D, (1996) Análise de custo-efetividade do componente de leishmaniose no Proje de Controle de Doenças Endêmicas no Nordeste do Brasil/Analysis of the cost-effectiveness of the leishmaniasis component of the Project for the Control of Endemic Diseases in the Northe. Rev patol trop 25: 203-252.
27. Lacerda M, (1994) The Brazilian Leishmaniasis Control Program. Mem Inst Oswaldo Cruz 89: 489-495.
28. Ershadi M, Zahraei-Ramazani A, Akhavan A, Jalali-Zand A, Abdoli H, et al. (2005) Rodent control operations against zoonotic cutaneous leishmaniasis in rural Iran. Ann Saudi Med 25: 309-312.
29. Gavgani ASM, Hodjati MH, Mohite H, Davies CR, (2002) Effect of insecticide-impregnated dog collars on incidence of zoonotic visceral leishmaniasis in Iranian children: a matched-cluster randomised trial. Lancet 360: 374-379 Available: http://www.ncbi.nlm.nih.gov/pubmed/12241778.
30. Dietze R, Barros GB, Teixeira L, Harris J, Michelson K, et al. (1997) Effect of eliminating seropositive canines on the transmission of visceral leishmaniasis in Brazil. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 25: 1240-1242 Available: http://www.ncbi.nlm.nih.gov/pubmed/9402389.
31. Ashford D, David JR, Freire M, David R, Sherlock I, et al. (1998) Studies on control of visceral leishmaniasis: impact of dog control on canine and human visceral leishmaniasis in Jacobina, Bahia, Brazil. The American journal of tropical medicine and hygiene 59: 53-57 Available: http://www.ncbi.nlm.nih.gov/pubmed/9684628.
32. Souza V, Julião F, Neves R, Magalhães P, Bisinotto T, et al. (2008) Communitary Assay for Assessment of Effectiveness of Strategies for Prevention and Control of Human Visceral Leishmaniasis in The Municipality of Feira de Santana, State of Bahia, Brazil. Epidemiol Serv Saúde, Brasília 17: 97-106.
33. Nery Costa HC, Tapety CMM, Werneck G, (2007) Controle da leishmaniose visceral em meio urbano: estudo de intervenção randomizado fatorial. Revista da Sociedade Brasileira de Medicina Tropical 40: 415-419.
34. Davies CR, Llanos-Cuentas E, Campos P, Monge J, Leon E, et al. (2000) Spraying houses in the Peruvian Andes with lambda-cyhalothrin protects residents against cutaneous leishmaniasis. Transactions of the Royal Society of Tropical Medicine and Hygiene 94: 631-636.
35. Reyburn H, Ashford R, Mohsen M, Hewitt S, Rowland M, (2000) A randomized controlled trial of insecticide-treated bednets and chaddars or top sheets, and residual spraying of interior rooms for the prevention of cutaneous leishmaniasis in Kabul, Afghanistan. Transactions of the Royal Society of Tropical Medicine and Hygiene 94: 361-366 Available: http://www.ncbi.nlm.nih.gov/pubmed/11127233.
36. Mayrink W, Da Costa CA, Magalhães PA, Melo MN, Dias M, et al. (1979) A field trial of a vaccine against American dermal leishmaniasis. Transactions of the Royal Society of Tropical Medicine and Hygiene 73: 385-387 Available: http://www.ncbi.nlm.nih.gov/pubmed/555064.
37. Ritmeijer K, Davies C, Van Zorge R, Wang S-J, Schorscher J, et al. (2007) Evaluation of a mass distribution programme for fine-mesh impregnated bednets against visceral leishmaniasis in eastern Sudan. Tropical medicine & international health 12: 404-414 Available: http://www.ncbi.nlm.nih.gov/pubmed/17313512.
38. Kelly DW, Mustafa Z, Dye C, (1997) Differential application of lambda-cyhalothrin to control the sandfly Lutzomyia longipalpis. Medical and veterinary entomology 11: 13-24 Available: http://www.ncbi.nlm.nih.gov/pubmed/9061673.
39. Alexander B, Young D, (1992) Dispersal of Phlebotomine sandflies (Diptera: Psychodidae) in a Colombian focus of Leishmania (Vianna) Braziliensis. Mem Inst Oswaldo Cruz 87: 397-403 Available: http://www.scielo.br/pdf/mioc/v87n3/vol87(f3)_068-074_100.pdf.
40. Ostyn B, Vanlerberghe V, Picado A, Dinesh DS, Sundar S, et al. (2008) Vector control by insecticide-treated nets in the fight against visceral leishmaniasis in the Indian subcontinent, what is the evidence? Tropical medicine & international health 13: 1073-1085 Available: http://www.ncbi.nlm.nih.gov/pubmed/18564350.
41. Moosa-Kazemi S, Yaghoobi-Ershadi M, Akhavan A, Abdoli H, Zahraei-Ramazani A, et al. (2007) Deltamethrin-impregnated bed nets and curtains in an anthroponotic cutaneous leishmaniasis control program in northeastern Iran. Ann Saudi Med 27: 6-12.
42. Jalouk L, Al Ahmed M, Gradoni L, Maroli M, (2007) Insecticide-treated bednets to prevent anthroponotic cutaneous leishmaniasis in Aleppo Governorate, Syria: results from two trials. Transactions of the Royal Society of Tropical Medicine and Hygiene 101: 360-367 Available: http://www.ncbi.nlm.nih.gov/pubmed/17097698.
43. Picado A, Singh SP, Rijal S, Sundar S, Ostyn B, et al. (2010) Longlasting insecticidal nets for prevention of Leishmania donovani infection in India and Nepal: paired cluster randomised trial. British Medical Journal 341: c6760-c6760 Available: http://www.bmj.com/cgi/doi/10.1136/bmj.c6760.
44. Mondal D, Alam MS, Karim Z, Haque R, Boelaert M, et al. (2008) Present situation of vector-control management in Bangladesh: a wake up call. Health policy (Amsterdam, Netherlands) 87: 369-376 Available: http://www.ncbi.nlm.nih.gov/pubmed/18342389.
45. Alten B, Caglar SS, Kaynas S, Simsek FM, (2003) Evaluation of protective efficacy of K-OTAB impregnated bednets for cutaneous leishmaniasis control in Southeast Anatolia-Turkey. Journal of vector ecology 28: 53-64.
46. Tayeh A, Jalouk L, Al-Khiami AM (1997) A Cutaneous Leishmaniasis Control Trial Using Pyrethroid-Impregnated Bednets in Villages near Aleppo, Syria. WHO WHO/LEISH/.
47. Motavalli-Emami M (2006) Impact of Olyset long lasting nets on anthroponotic cutaneous leishmaniasis in Islamic Republic of Iran. WHO Results Portfolio 3 WHO-EM/TDR/110/E. Available: http://applications.emro.who.int/dsaf/dsa744.pdf.
48. Lengeler C, (2006) Insecticide-treated bed nets and curtains for preventing malaria (Review). Cochrane Database of Systematic Reviews doi:10.1002/14651858.CD000363.pub2.
49. Goodman CA, Coleman PG, Mills J, (1999) Cost-effectiveness of malaria control in sub-Saharan Africa. Lancet 354: 378-385 Available: http://www.ncbi.nlm.nih.gov/pubmed/10437867.
50. Soto J, Medina F, Dember N, Berman J, (1995) Efficacy of permethrin-impregnated uniforms in the prevention of malaria and leishmaniasis in Colombian soldiers. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 21: 599-602 Available: http://www.ncbi.nlm.nih.gov/pubmed/8527550.
51. Asilian A, Sadeghinia A, Shariati F, Imam Jome M, Ghoddusi A, (2003) Efficacy of permethrin-impregnated uniforms in the prevention of cutaneous leishmaniasis in Iranian soldiers. Journal of clinical pharmacy and therapeutics 28: 175-178 Available: http://www.ncbi.nlm.nih.gov/pubmed/12795775.
52. Kroeger A, Avila EV, Morison L, (2002) Insecticide impregnated curtains to control domestic transmission of cutaneous leishmaniasis in Venezuela: cluster randomised trial. BMJ (Clinical research ed) 325: 810-813 Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=128948&tool=pmcentrez&rendertype=abstract.
53. Khamesipour A, Rafati S, Davoudi N, Maboudi F, Modabber F, (2006) Leishmaniasis vaccine candidates for development: a global overview. The Indian journal of medical research 123: 423-438 Available: http://www.ncbi.nlm.nih.gov/pubmed/16778321.
54. Khalil E a, El Hassan M, Zijlstra EE, Mukhtar MM, Ghalib HW, et al. (2000) Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: a randomised, double-blind, BCG-controlled trial in Sudan. Lancet 356: 1565-1569 Available: http://www.ncbi.nlm.nih.gov/pubmed/11075771.
55. Duthie MS, Raman VS, Piazza FM, Reed SG, (2012) The development and clinical evaluation of second-generation leishmaniasis vaccines. Vaccine 30: 134-141 Available: http://www.ncbi.nlm.nih.gov/pubmed/22085553.
56. Mayrink W, Williams P, Da Costa CA, Magalhães PA, Melo MN, et al. (1985) An experimental vaccine against American dermal leishmaniasis: experience in the State of Espírito Santo, Brazil. Annals of tropical medicine and parasitology 79: 259-269 Available: http://www.ncbi.nlm.nih.gov/pubmed/4026438.
57. Armijos RX, Weigel MM, Calvopina M, Hidalgo a, Cevallos W, et al. (2004) Safety, immunogenecity, and efficacy of an autoclaved Leishmania amazonensis vaccine plus BCG adjuvant against New World cutaneous leishmaniasis. Vaccine 22: 1320-1326 Available: http://www.ncbi.nlm.nih.gov/pubmed/15003662.
58. Rojas CA, Weigle KA, Tovar R, Morales AL, Alexander B, et al. (2006) A multifaceted intervention to prevent American cutaneous leishmaniasis in Colombia: results of a group-randomized trial. Biomédica: revista del Instituto Nacional de Salud 26: 152-166.
59. González U, Pinart M, (2010) Preventive measures for leishmaniasis (Protocol). Cochrane Database of Systematic Reviews Available: http://doi.wiley.com/10.1002/14651858.
60. Khanjani N, González U, Leonardi-Bee J, Mohebali M, Saffari M, et al. (2009) Vaccines for preventing cutaneous leishmaniasis (Protocol). Cochrane Database of Systematic Reviews 2009: CD007634 DOI:10.1002/14651858.CD007634.
61. Alvar J, González U, Pinart M, Kalita S, Herrero M, et al. (2010) Interventions for visceral leishmaniasis (Protocol). Cochrane Database of Systematic Reviews 2010: CD008561 DOI:10.1002/14651858.CD008561.
62. Nadim A, Motabar M, Houshmand B, Kayghobadi K, Aflatonian M, (1995) Evaluation of pyrethroid impregnated bednets for control of anthroponotic cutaneous leishmaniasis in Bam (Islamic Republic of Iran). WHO pp. 1-21.
63. Khalil EAG, Musa AM, Modabber F, El-Hassan AM, (2006) Safety and immunogenicity of a candidate vaccine for visceral leishmaniasis (Alum-precipitated autoclaved Leishmania major + BCG) in children: an extended phase II study. Annals of tropical paediatrics 26: 357-361 Available: http://www.ncbi.nlm.nih.gov/pubmed/17132302.
64. Armijos RX, Weigel MM, Romero L, Garcia V, Salazar J, (2003) Field trial of a vaccine against new world cutaneous leishmaniasis in an at-risk child population: how long does protection last? The Journal of infectious diseases 187: 1959-1961 Available: http://www.ncbi.nlm.nih.gov/pubmed/12792873.
65. O'Daly Carbonell JA, Spinetti H, Rodríguez MB, Acuña L, García P, et al. (1995) Proteínas de amastigotes de varias especies de leishmanias protegen a seres humanos contra la leishmaniasis en el área endémica de Guatire, Estado Miranda, Venezuela. Gac Méd Caracas 103: 133-145.
66. Velez ID, Gilchrist K, Arbelaez MP, Rojas Ca, Puerta Ja, et al. (2005) Failure of a killed Leishmania amazonensis vaccine against American cutaneous leishmaniasis in Colombia. Transactions of the Royal Society of Tropical Medicine and Hygiene 99: 593-598 Available: http://www.ncbi.nlm.nih.gov/pubmed/15893351.
67. Momeni A, Jalayer T, Emamjomeh M, Khamesipour A, Zicker F, et al. (1998) A randomised, double-blind, controlled trial of a killed L. major vaccine plus BCG against zoonotic cutaneous leishmaniasis in Iran. Vaccine 17: 466-472 Available: http://www.ncbi.nlm.nih.gov/pubmed/10073725.
68. Sharifi I, FeKri aR, Aflatonian MR, Khamesipour a, Nadim a, et al. (1998) Randomised vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, Iran. Lancet 351: 1540-1543 Available: http://www.ncbi.nlm.nih.gov/pubmed/10326536.
69. Antunes CM, Mayrink W, Magalhaes Pa, Costa Ca, Melo MN, et al. (1986) Controlled field trials of a vaccine against New World cutaneous leishmaniasis. International journal of epidemiology 15: 572-580 Available: http://www.ncbi.nlm.nih.gov/pubmed/3546170.